000 01218 a2200337 4500
005 20250516212150.0
264 0 _c20140522
008 201405s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc1316382
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhu, Hong-Hu
245 0 0 _aResistance to arsenic therapy in acute promyelocytic leukemia.
_h[electronic resource]
260 _bThe New England journal of medicine
_cMay 2014
300 _a1864-6 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aArsenic Trioxide
650 0 4 _aArsenicals
_xtherapeutic use
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeukemia, Promyelocytic, Acute
_xdrug therapy
650 0 4 _aMutation
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aOxides
_xtherapeutic use
650 0 4 _aReceptors, Retinoic Acid
_xgenetics
650 0 4 _aRetinoic Acid Receptor alpha
700 1 _aQin, Ya-Zhen
700 1 _aHuang, Xiao-Jun
773 0 _tThe New England journal of medicine
_gvol. 370
_gno. 19
_gp. 1864-6
856 4 0 _uhttps://doi.org/10.1056/NEJMc1316382
_zAvailable from publisher's website
999 _c23804698
_d23804698